stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? having presented their first symptomatic unilateral ischemic or hemorrhagic stroke as proven by magnetic resonance imaging or computed tomography; ? having been proved shoulder hand syndrome; ? having the ability to cooperate with the completion of assessment and treatment; ? between the ages of 18-80 years and signed an informed consent form; ? having stable vital signs and neurological symptoms are no longer progressive; ? no serious disease such as serious heart disease, renal insufficiency or malignant tumor.
Exclusion criteria
Exclusion criteria: ? deterioration of condition; ? the patient had contraindications of other infectious diseases, erysipelas, venous thrombosis and other manipulative lymphatic drainage; ? unable to adhere to the treatment; ? patients with damaged upper extremity skin that is not suitable for kinesio-tape; ? the pain is caused by other diseases such as shoulder periarthritis, cervical spondylosis or myocardial infarction; ? with dysfunction of the heart, lung, liver, kidney and other important organs or other serious physical diseases; ? participants enrolled in other clinical trials; ? patients who had received other treatment for edema or pain prior to inclusion in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fugl-Meyer Assessment Upper Extremity Scale;modified Barthel index;Upper limb volume difference;Range of motion;SS-QOL; | — |
Countries
China
Contacts
Army Medical Center of PLA